Comparison of the outcomes of modified artificial chordae technique for
mitral regurgitation through right minithoracotomy or median sternotomy.
We believe the addition of Harpoon Medical's technology and team will enable even more opportunities to help patients with degenerative
mitral regurgitation," said Bernard Zovighian, Edwards' corporate vice president, surgical heart valve therapy.
If you do suffer from
mitral regurgitation, it's not too late to make some changes to help your heart function at its best.
The Intrepid TMVR System is easy to implant in the challenging mitral anatomy due to its conformable, dual stent design and the device corrects the underlying
mitral regurgitation in a significant majority of patients.
Despite significant advances in the understanding of valve disease,
mitral regurgitation has until now been largely considered a degenerative disorder, resulting from a weakening of the valve over time due to 'wear and tear'.
Mitral regurgitation was found in 141(54%) patients in whom 104(74%) patients were found to have mild
mitral regurgitation, 29(20%) patients were found to have moderate
mitral regurgitation and 8(6%) patients were having severe
mitral regurgitation.
All the patients with diabetes, hypertension, suboptimal PTMC,
mitral regurgitation more than Grade-1, Aortic regurgitation more than grade 1, evidence of coronary artery disease or left ventricle ejection fraction(LVEF) <40% were excluded from the study.
Mitral regurgitation was diagnosed by the presence of thickened valves, dilated mitral valve annuli, and left atrial and left ventricular dilatation, and lack of coaptation of the mitral valve leaflets in systole.
The cause of
mitral regurgitation was rheumatic in all patients, with no congenital myxomatous, infective or ischemic cases.
Severe functional
mitral regurgitation Percutaneous mitral valve repair with the mitraclip system, a safe option for patients who can not be taken to surgery
The company has announced that the Amend has now been successfully used in initial procedures on human patients in Italy and Israel, potentially paving way for adoption of the technology for treating
mitral regurgitation.
An echocardiogram revealed massive
mitral regurgitation and a left ventricular ejection fraction of 32%.
